NEW DELHI: The Delta variant of novel coronavirus is eight times less sensitive to antibodies generated by vaccines as compared to the original strain that came from China’s Wuhan, according to a new study.The study, which was conducted on more than 100 healthcare workers (HCWs) at three centres in India including Sir Ganga Ram Hospital (SGRH), found that the B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-Delta infections but also generates greater transmission among the fully vaccinated HCWs. The collaborative study, “Sars-Cov-2 B.1.617.2 Delta Variant Emergence and Vaccine Breakthrough: Collaborative Study”, from India with scientists from Cambridge Institute of Therapeutic Immunology and Infectious Disease is yet to be peer-reviewed.
“From this study, it appears that we have miles to go before we sleep in case of Covid-19 pandemic. Mutations are bound to happen if we lower our guard and allow ourselves to fall prey to this virus, giving it an opportunity to multiply,” said Dr Chand Wattal, chairperson of the Institute of Clinical Microbiology and Immunology, SGRH.
“This is a straight eye-opener to the fully vaccinated people that you cannot lower guard in the name of vaccination. The virus is on the prowl, still looking for its prey. This mutant has come back with enhanced spike proteins for attachment to the lung epithelial cells which have provided it with a much higher capacity to infect many more people than the Wuhan strain,” he said.
The data also indicates that the dominance of the Delta variant in India has been most likely driven by a combination of evasion of neutralising antibodies in previously infected individuals and increased virus infectivity resulting in the second wave, the study said.
